Benzinga | Jan 18, 2022 10:55AM EST

Goldman Sachs Maintains Neutral on Medtronic, Lowers Price Target to $115

Goldman Sachs maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price target from $129 to $115.